Comparison of CMF (Cyclophosphamide, Methotrexate, and 5-Fluorouracil) With a Rotational Crossing and a Sequential Intensification Regimen in Advanced Breast CancerGiorgio Cocconi, Paola Buzzi, Giancarlo Bisagni et al.|American Journal of Clinical Oncology|1999Cited by 10
Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Change of Molecular Subtype at Re-Biopsy. Insights from the GIM-13 - AMBRA StudyMarina Elena Cazzaniga, Giorgio Mustacchi, Francesco Atzori et al.|Preprints.org|2025Cited by 0